Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 224

1.

Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A.

Holtwick R, van Eickels M, Skryabin BV, Baba HA, Bubikat A, Begrow F, Schneider MD, Garbers DL, Kuhn M.

J Clin Invest. 2003 May;111(9):1399-407.

2.

Vascular endothelium is critically involved in the hypotensive and hypovolemic actions of atrial natriuretic peptide.

Sabrane K, Kruse MN, Fabritz L, Zetsche B, Mitko D, Skryabin BV, Zwiener M, Baba HA, Yanagisawa M, Kuhn M.

J Clin Invest. 2005 Jun;115(6):1666-74.

3.

Hypervolemic hypertension in mice with systemic inactivation of the (floxed) guanylyl cyclase-A gene by alphaMHC-Cre-mediated recombination.

Skryabin BV, Holtwick R, Fabritz L, Kruse MN, Veltrup I, Stypmann J, Kirchhof P, Sabrane K, Bubikat A, Voss M, Kuhn M.

Genesis. 2004 Aug;39(4):288-98.

PMID:
15287002
4.

Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure.

Kuhn M, Voss M, Mitko D, Stypmann J, Schmid C, Kawaguchi N, Grabellus F, Baba HA.

Cardiovasc Res. 2004 Nov 1;64(2):308-14.

PMID:
15485690
5.

Local atrial natriuretic peptide signaling prevents hypertensive cardiac hypertrophy in endothelial nitric-oxide synthase-deficient mice.

Bubikat A, De Windt LJ, Zetsche B, Fabritz L, Sickler H, Eckardt D, Gödecke A, Baba HA, Kuhn M.

J Biol Chem. 2005 Jun 3;280(22):21594-9. Epub 2005 Mar 26.

6.

Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart.

Li Y, Kishimoto I, Saito Y, Harada M, Kuwahara K, Izumi T, Takahashi N, Kawakami R, Tanimoto K, Nakagawa Y, Nakanishi M, Adachi Y, Garbers DL, Fukamizu A, Nakao K.

Circulation. 2002 Sep 24;106(13):1722-8.

7.

Enhanced activity of the myocardial Na+/H+ exchanger NHE-1 contributes to cardiac remodeling in atrial natriuretic peptide receptor-deficient mice.

Kilic A, Velic A, De Windt LJ, Fabritz L, Voss M, Mitko D, Zwiener M, Baba HA, van Eickels M, Schlatter E, Kuhn M.

Circulation. 2005 Oct 11;112(15):2307-17.

8.
9.

Altered expression of atrial natriuretic peptide and contractile protein genes in hypertrophied ventricle of JVS mice with systemic carnitine deficiency.

Yoshimine K, Horiuchi M, Suzuki S, Kobayashi K, Abdul JM, Masuda M, Tomomura M, Ogawa Y, Itoh H, Nakao K, Osame M, Saheki T.

J Mol Cell Cardiol. 1997 Feb;29(2):571-8.

PMID:
9140816
10.

Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides-guanylyl cyclase-A signaling in the heart.

Kinoshita H, Kuwahara K, Nishida M, Jian Z, Rong X, Kiyonaka S, Kuwabara Y, Kurose H, Inoue R, Mori Y, Li Y, Nakagawa Y, Usami S, Fujiwara M, Yamada Y, Minami T, Ueshima K, Nakao K.

Circ Res. 2010 Jun 25;106(12):1849-60. doi: 10.1161/CIRCRESAHA.109.208314. Epub 2010 May 6.

11.

Cardiac-specific attenuation of natriuretic peptide A receptor activity accentuates adverse cardiac remodeling and mortality in response to pressure overload.

Patel JB, Valencik ML, Pritchett AM, Burnett JC Jr, McDonald JA, Redfield MM.

Am J Physiol Heart Circ Physiol. 2005 Aug;289(2):H777-84. Epub 2005 Mar 18.

12.

Ventricular expression of natriuretic peptides in Npr1(-/-) mice with cardiac hypertrophy and fibrosis.

Ellmers LJ, Knowles JW, Kim HS, Smithies O, Maeda N, Cameron VA.

Am J Physiol Heart Circ Physiol. 2002 Aug;283(2):H707-14.

13.

Novel insights into the mechanisms mediating the local antihypertrophic effects of cardiac atrial natriuretic peptide: role of cGMP-dependent protein kinase and RGS2.

Klaiber M, Kruse M, Völker K, Schröter J, Feil R, Freichel M, Gerling A, Feil S, Dietrich A, Londoño JE, Baba HA, Abramowitz J, Birnbaumer L, Penninger JM, Pongs O, Kuhn M.

Basic Res Cardiol. 2010 Sep;105(5):583-95. doi: 10.1007/s00395-010-0098-z. Epub 2010 Mar 30.

14.

Altered expression of natriuretic peptide receptors in proANP gene disrupted mice.

Vera N, Tse MY, Watson JD, Sarda S, Steinhelper ME, John SW, Flynn TG, Pang SC.

Cardiovasc Res. 2000 Jun;46(3):595-603.

PMID:
10912470
15.

A cardiac pathway of cyclic GMP-independent signaling of guanylyl cyclase A, the receptor for atrial natriuretic peptide.

Klaiber M, Dankworth B, Kruse M, Hartmann M, Nikolaev VO, Yang RB, Völker K, Gassner B, Oberwinkler H, Feil R, Freichel M, Groschner K, Skryabin BV, Frantz S, Birnbaumer L, Pongs O, Kuhn M.

Proc Natl Acad Sci U S A. 2011 Nov 8;108(45):18500-5. doi: 10.1073/pnas.1103300108. Epub 2011 Oct 25.

16.

Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase I.

Frantz S, Klaiber M, Baba HA, Oberwinkler H, Völker K, Gaβner B, Bayer B, Abeβer M, Schuh K, Feil R, Hofmann F, Kuhn M.

Eur Heart J. 2013 Apr;34(16):1233-44. doi: 10.1093/eurheartj/ehr445. Epub 2011 Dec 23.

17.

Increased susceptibility to heart failure in response to volume overload in mice lacking natriuretic peptide receptor-A gene.

Nishikimi T, Hagaman JR, Takahashi N, Kim HS, Matsuoka H, Smithies O, Maeda N.

Cardiovasc Res. 2005 Apr 1;66(1):94-103. Epub 2005 Jan 15.

PMID:
15769452
18.

Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides.

Tokudome T, Horio T, Kishimoto I, Soeki T, Mori K, Kawano Y, Kohno M, Garbers DL, Nakao K, Kangawa K.

Circulation. 2005 Jun 14;111(23):3095-104. Epub 2005 Jun 6.

19.
20.

Differential expression of natriuretic peptides and their receptors in volume overload cardiac hypertrophy in the rat.

Su X, Brower G, Janicki JS, Chen YF, Oparil S, Dell'Italia LJ.

J Mol Cell Cardiol. 1999 Oct;31(10):1927-36.

PMID:
10525429

Supplemental Content

Support Center